Nicotinamide (niacinamide) may help reduce your chances of developing basal cell carcinoma, squamous cells carcinoma and actinic keratosis. This is not just wishful thinking but based upon a well designed Australian clinical study in which they used a dose of 500 milligrams twice a day. Unlike nicotinic acid, nicotinamide does not improve blood cholesterol… Read More: Nicotinamide For Skin Cancer »
Cancer survival in the UK is on the up, but is still lagging behind other high-income countries, analysis suggests. Five-year survival rates for rectal and colon cancer improved the most since 1995, and pancreatic cancer the least. Advances in treatment and surgery are thought to be behind the UK’s progress. But the UK still performed… Read More: Cancer survival in the UK improving, but lagging behind –… »
September marks Ovarian Cancer Awareness Month. Learn more about the women who beat the odds and overcame this disease referred to by many in the medical community as a “silent killer.” The silent killer Ricardo Serra/Shutterstock One in 78 women will develop ovarian cancer in her lifetime yet despite its prevalence, this disease is often… Read More: 12 Women You Didn’t Know Overcame Ovarian Cancer »
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann (Reuters) – Roche Holding AG has priced at about $ 204,560 a year its personalized cancer treatment, Rozlytrek, that targets tumors with specific genetic mutations, the Swiss drugmaker said. The treatment will cost about… Read More: Roche personalized cancer treatment to cost about $204,560 a year »